Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

TTP Labtech Announces On-Going Growth

Published: Thursday, July 11, 2013
Last Updated: Thursday, July 11, 2013
Bookmark and Share
An investment of £3.8M in global R&D sees product sales grow over 20%.

TTP Labtech has reported details of its success in 2012, as well as its growth plans for 2013. Continuing its track record of pioneering automation drug discovery products, TTP Labtech’s £3.8M investment in R&D and entrance into new markets paid off as product sales for 2012 were up over 20 percent compared to the year previous, despite the challenging economy. This progress was driven by launching products into new markets, including biological sample storage and liquid handling for molecular biology applications, as well as continued growth in the sale of established products. 

“Many drug discovery laboratories are facing challenging circumstances that require them to continually optimise their screening strategies and harness more automation,” said Jas Sanghera, TTP Labtech’s Managing Director. “We’re poised to embrace these changes in the environment by driving the development of solutions that meet the ever-evolving needs of our customers and applying this insight to new market sectors.” 

As such, the company shifted emphasis slightly during 2012 to make more effective use of its considerable product development expertise, positioning it for strong growth this year. “When we started over a decade ago, we primarily provided consultative insight for customers requiring bespoke automated platforms,” commented Sanghera. “However, over the last few years, our internal R&D teams have proved time and time again to be exceptionally good at developing innovative new automated technologies that truly meet customer needs. In 2012, we continued to invest in our product development capabilities and see product sales as being a strong driver of revenue growth into 2013 and beyond.”

This approach has included optimising every department within the company to reflect the growing focus on the continual development of automated instrumentation for the life science industry. Importantly, TTP Labtech uses its consultative experience to help customers develop new applications and techniques, with customer needs forming a key driving force behind its R&D programs. 

“We trust the team at TTP Labtech implicitly, they always listen to us.” said Jose Quiroz of Dart NeuroScience LLC. “We have developed such good working relationships with them that we consider them friends – their engineering and support teams regularly visit us to follow-up on our progress. Their applications support has always been second to none.”  

Last year, the company introduced an automated -80°C biological sample management system for biobanking called arktic® and the dragonfly, a new liquid handler specifically developed for screen optimisation. Both have been enthusiastically welcomed by the market and are expected to perform well in 2013. The mirrorball® antibody discovery system, which was introduced in late 2011 and is the world’s first simultaneous multi-laser scanning system, is also rapidly gaining traction in the pharmaceutical and biotech sectors, and will start to significantly impact revenues during 2013. Furthermore, the new high content imager, acumen hci, is extremely well positioned to handle the high throughput imaging and analysis of complex cellular assays, which is now common place in the high content screening market. 

This year, the company will look to target the field of molecular biology. “Many of our products are well positioned to provide real value to customers carrying out analysis applications such as next generation sequencing (NGS) and qPCR by improving the efficiency and speed of sample preparation, as well as improving functional genomics studies, for example via automated RNAi screens,” said Sanghera. “With significant opportunities in this space and several other major product developments coming in 2013, these are exciting times for TTP Labtech.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

TTP Labtech will Showcase its Latest Automated Technology Innovations in Europe
Delivering a wealth of new products to the attendees of ELA 2012.
Monday, May 21, 2012
TTP LabTech's European Roadshow
The roadshow offers the opportunity to try out the latest in low-volume liquid handling and high content screening systems, as well as learning more about compound management, instrumentation development and custom automation.
Thursday, September 13, 2007
TTP LabTech Announce US Expansion to Meet Growing Customer Demand
TTP LabTech further expands its US facilities with the recruitment of sales and customer service personnel for its East Coast office in Cambridge, MA.
Monday, July 30, 2007
TTP Extends Global Reach
After building up a strong base of customers in the USA and Europe over the past three years, TTP LabTech have now appointed distributors for Japan, India and Australia/New Zealand.
Wednesday, April 04, 2007
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Batten Disease may Benefit from Gene Therapy
NIH-funded animal study suggests one-shot approach to injecting genes.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Molecule Proves Key to Brain Repair After Stroke
Scientists found that a molecule known as growth and differentiation factor 10 (GDF10) plays a key role in repair mechanisms following stroke.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos